Nothing Special   »   [go: up one dir, main page]

BE1030504B1 - Insert composite pour le traitement de la sécheresse oculaire - Google Patents

Insert composite pour le traitement de la sécheresse oculaire

Info

Publication number
BE1030504B1
BE1030504B1 BE20225347A BE202205347A BE1030504B1 BE 1030504 B1 BE1030504 B1 BE 1030504B1 BE 20225347 A BE20225347 A BE 20225347A BE 202205347 A BE202205347 A BE 202205347A BE 1030504 B1 BE1030504 B1 BE 1030504B1
Authority
BE
Belgium
Prior art keywords
treatment
dry eye
composite insert
mass
cellulose derivative
Prior art date
Application number
BE20225347A
Other languages
English (en)
Other versions
BE1030504A1 (fr
Inventor
Fabienne Wijzen
Ingeborg Hoffelinck
Original Assignee
Eyed Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eyed Pharma filed Critical Eyed Pharma
Priority to BE20225347A priority Critical patent/BE1030504B1/fr
Priority to PCT/EP2023/061965 priority patent/WO2023214027A1/fr
Publication of BE1030504A1 publication Critical patent/BE1030504A1/fr
Application granted granted Critical
Publication of BE1030504B1 publication Critical patent/BE1030504B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un insert ophthalmique biorésorbable comprenant au moins 25% en masse d’un premier dérivé de cellulose étant l’hydroxypropyle cellulose (HPC), ladite HPC ayant une masse moléculaire compris entre 800000 et 120000 Da, et entre 1 et 75% en masse d’un agent de viscosité constitué de l’hyaluronate de sodium, ou d’un second dérivé de cellulose différent de du premier dérivé de cellulose et procédés de fabrication par extrusion ou moulage.
BE20225347A 2022-05-06 2022-05-06 Insert composite pour le traitement de la sécheresse oculaire BE1030504B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BE20225347A BE1030504B1 (fr) 2022-05-06 2022-05-06 Insert composite pour le traitement de la sécheresse oculaire
PCT/EP2023/061965 WO2023214027A1 (fr) 2022-05-06 2023-05-05 Insert pour le traitement des yeux secs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE20225347A BE1030504B1 (fr) 2022-05-06 2022-05-06 Insert composite pour le traitement de la sécheresse oculaire

Publications (2)

Publication Number Publication Date
BE1030504A1 BE1030504A1 (fr) 2023-11-29
BE1030504B1 true BE1030504B1 (fr) 2023-12-04

Family

ID=81748817

Family Applications (1)

Application Number Title Priority Date Filing Date
BE20225347A BE1030504B1 (fr) 2022-05-06 2022-05-06 Insert composite pour le traitement de la sécheresse oculaire

Country Status (1)

Country Link
BE (1) BE1030504B1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343787A (en) * 1975-07-29 1982-08-10 Merck & Co., Inc. Shaped ophthalmic inserts for treating dry eye syndrome
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
US20080193407A1 (en) * 2007-02-09 2008-08-14 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US20110129516A1 (en) * 2009-10-30 2011-06-02 Aton Pharma, Inc. Ocular drug delivery devices

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845201A (en) 1972-04-24 1974-10-29 S Loucas Solid state ophthalmic medication delivery method
DK137946B (da) 1973-12-17 1978-06-12 Merck & Co Inc Bæremedium i fast form til anvendelse i ophthalmiske præparater.
US6217896B1 (en) 1999-04-01 2001-04-17 Uab Research Foundation Conjunctival inserts for topical delivery of medication or lubrication

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343787A (en) * 1975-07-29 1982-08-10 Merck & Co., Inc. Shaped ophthalmic inserts for treating dry eye syndrome
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
US20080193407A1 (en) * 2007-02-09 2008-08-14 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US20110129516A1 (en) * 2009-10-30 2011-06-02 Aton Pharma, Inc. Ocular drug delivery devices

Also Published As

Publication number Publication date
BE1030504A1 (fr) 2023-11-29

Similar Documents

Publication Publication Date Title
Sterner et al. Reducing friction in the eye: a comparative study of lubrication by surface-anchored synthetic and natural ocular mucin analogues
ATE273324T1 (de) Heparinähnliche sulfatierte polysaccharide
TW393498B (en) The preparation and use of Polysiloxane-comprising perfluoroalkyl ethers
AR049057A2 (es) Una tableta rapidamente desintegrable para la administracion por via oral
BE1030504B1 (fr) Insert composite pour le traitement de la sécheresse oculaire
JPH10508204A (ja) イズロン酸を高含有量有する多糖類
ES2082800T3 (es) Hidroxietilalmidon como diluyente del plasma y su procedimiento de preparacion.
TW201636026A (zh) 滴眼劑及其所包含之共聚物之用途
CA2216919A1 (fr) Nanospheres contenant un polysaccharidique biocompatible
AlKhoury et al. Study on the potential mechanism of anti‐inflammatory activity of covalently immobilized hyaluronan and heparin
TWI798452B (zh) 隱形眼鏡產品
BR112022016415A2 (pt) Múltiplas chamadas de base à base de inteligência artificial
BR112022015380A2 (pt) Composições e métodos para edição de gene de calicreína (klkb1)
CO5140079A1 (es) Composicion farmaceutica de liberacion sostenida y metodo para liberar un agente farmaceuticamente activo de liberacion sostenida y metodo para liberar un agente far- maceuticamente activo
US20040127461A1 (en) Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
WO2023235838A3 (fr) Modificateurs d'épissage ciblant l'arn pour le traitement d'affections et de maladies associées à foxp3
HUP9903666A2 (hu) Eljárás alacsony polidiszperziós indexű hialuronsav-frakció előállítására
FI972527A0 (fi) Pinnoitusmenetelmä
TW201900786A (zh) 矽酮水凝膠隱形眼鏡用溶液及其配送液
DE69527081D1 (de) Mehrfach ungesättigte kohlenhydratderivate, polymere davon und deren verwendung
Khangtragool et al. Chitosan as an ocular drug delivery vehicle for vancomycin
BE1030503B1 (fr) Insert pour le traitement de la sécheresse oculaire
AR004360A1 (es) Composiciones farmaceuticas para la terapia de carcinomas del epitelio plano y un agente para ser empleado en estas composicines farmaceuticas.
WO2022010939A3 (fr) Peptides et leurs méthodes d'utilisation
JP4290231B2 (ja) 角膜障害症治癒促進剤

Legal Events

Date Code Title Description
FG Patent granted

Effective date: 20231204